Massive Bio, NeoGenomics Collaborate on AI-Driven Oncology Clinical Trial Matching
By combining their cancer diagnostics and bioinformatics capabilities, the companies hope to speed up cancer drug discovery.
New Products Posted to GenomeWeb: Illumina, NeoGenomics, Bionano Laboratories
New products and services posted to GenomeWeb for the week of March 13, 2023.
GenomeWeb Top 40 Down 4 Percent in February, Tracking Broader Market
The Dow Jones Industrial Average was down 4 percent, while the Nasdaq was down 1 percent, and the Nasdaq Biotech Index was down 7 percent.
The company's Q4 revenues grew 10 percent and full-year revenues increased 5 percent, exceeding analysts' average estimates.
Data from an early-phase trial has spurred the firm to validate its blood-based residual disease assay, Radar, in neoadjuvant bladder cancer.
Dec 12, 2022
Nov 8, 2022
Aug 9, 2022
Apr 28, 2022